Compare Organon Pharma Indonesia Tbk. (SCPI) vs Total Bangun Persada Tbk. (TOTL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon Pharma Indonesia Tbk. vs Total Bangun Persada Tbk. — how do they compare? Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B), while Total Bangun Persada Tbk. trades at Rp1,500 (market cap 5.15T, 2.02M 24h volume). The key difference: Total Bangun Persada Tbk. is far larger — about 49.3× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| SCPI | TOTL | |
|---|---|---|
Market Cap | 104.4B | 5.15T |
Volume | — | 2.02M |
Lot | — | 20.21K |
Turnover | — | 3B |
Average Price | — | 1,485.19 |
Value | — | 3B |
Indicative Equilibrium Price | — | 1,500 |
Indicative Equilibrium Volume | — | 482 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →About Total Bangun Persada Tbk.
PT Total Bangun Persada (the company) was established under its original name of PT Tjahja Rimba Kentjana on Sep 4, 1970 then changed to PT Total Bangun Persada based on Notaries Deed dated Jul 24, 1981 and the deed of establishment was approved by the the Ministry of Justice dated Nov 4, 1981. The Company’s articles of association has been amended several times, most recently by notarial deed No. 47 of Haryanto, S.H., dated Oct 24, 2005, concerning the amendment of Company's authorized and paid up capital, and public offering.
Read more on TOTL →
